Stop Romanticizing Death
A healthspan response to Time’s “What Can We Learn From Death?”
Opinion piece — not medical advice. Statistics and clinical claims below cite public health sources where noted; longevity escape velocity remains a theoretical concept.
In a recent Time article titled “What Can We Learn From Death?”, journalist Arianna Huffington argues that reflecting on mortality sharpens our priorities and deepens our appreciation for life. The premise is familiar: the awareness of death gives life meaning.
There is emotional truth in that idea. But there is also a blind spot.
When mortality is framed primarily as a teacher, we risk normalizing biological decline as something beyond meaningful intervention. History suggests the opposite lesson. Human progress has never been driven by accepting biological limits. It has been driven by systematically extending them.
The Historical Record: Intervention Extends Life
In 1900, global life expectancy was approximately 31 years. In the United States, it was 47. Today, global life expectancy exceeds 72 years, and in Singapore it surpasses 83.2 and rising, giving Singapore the official designation of Blue Zone 2.0.
This global doubling in life expectancy did not occur because we reflected more deeply on death. The average human lifespan doubled due to innovations such as vaccination, pasteurization, chlorine, and penicillin.
Every major increase in human lifespan has come from innovation and intervention, not acceptance. Modern medicine exists because previous generations refused to stop at brooding over the meaning in the inevitability of death, and so should we.
Most Death Is Not “Natural.” It Is Pathological.
According to the World Health Organization, approximately 74 percent of global deaths are caused by chronic diseases. Cardiovascular disease alone accounts for nearly 20 million deaths annually.
These are not abstract inevitabilities. They are driven by measurable biological processes. We can identify and address: elevated ApoB and cumulative LDL particle exposure; insulin resistance and hyperglycemia; chronic inflammation; hypertension; sedentary physiology; tobacco exposure.
Coronary plaque develops silently for decades before the first cardiac event. Type 2 diabetes can be detected years before diagnosis through metabolic markers. VO2 max, one of the strongest predictors of all-cause mortality, is both measurable and trainable.
Aging is not a philosophical abstraction. It is the accumulation of cellular and molecular damage across systems: genomic instability, mitochondrial dysfunction, loss of proteostasis, immune dysregulation.
We can quantify these processes. Increasingly, we can influence them. And for conditions we cannot yet, as humanity we push forward with research and innovation to be able to do so in the long arc of time.
Inevitability Is Not Endorsement
Death remains inevitable today. That is true. But inevitability does not mean we should minimize our ambition to delay it.
Gravity is inevitable. We built aircraft. Infectious disease was inevitable. We built vaccines. Cardiovascular mortality was inevitable. We built preventive cardiology.
The doubling of human lifespan over the last century should caution us against assuming we are near the limit of biological extension. If anything, it tells us that likely there is no ceiling except for what we tacitly accede.
Which brings us to a concept rarely discussed in mainstream commentary: longevity escape velocity.
Longevity Escape Velocity
The term describes a point at which medical advances extend life expectancy faster than biological aging shortens it. In simple terms, if science can add more than one year of healthy life for every year that passes, lifespan can continue extending in step with innovation.
We are not there yet.
But the trajectory is no longer speculative. Advances in epigenetic age measurement, precision oncology, lipid-lowering therapy, GLP-1 receptor agonists, cellular senescence research, and AI-assisted diagnostics are accelerating humanity’s push toward this frontier.
When viewed through this lens, the appropriate response to mortality is not resignation. It is defiance.
The Moral Imperative of Healthspan
At Elyx, we frame this differently from cultural commentary.
Living as long and as healthily as possible is not vanity. It is responsibility.
The longer one maintains cognitive clarity, metabolic resilience, and physical capacity, the longer one can contribute to family, community, and enterprise. Chronic disease is not only a personal burden. It is a societal one.
If tools exist that can measurably delay dysfunction and extend vitality, there is a moral obligation to use them and to help others access them.
“Extending healthspan is not about denying death. It is about maximizing contribution before it.”
Reflection Is Incomplete Without Intervention
The Time article suggests that confronting death helps us prioritize what matters.
Reflection has value.
But reflection does not lower ApoB. Perspective does not reverse insulin resistance. Gratitude does not regress arterial plaque.
Intervention does.
Death may be inevitable for now. Decline is not.
A Better Question
In addition to asking what we can learn from death, perhaps we should ask: what can we learn from biology about postponing it?
Every major advance in medicine was once considered unnecessary or unnatural. Anesthesia, IVF, transplantation, statins, immunotherapy. All controversial. All standard today.
Longevity medicine is not just a philosophical defiance. It is continuity with the arc of human progress.
If mortality once defined the boundary of human ambition, science is steadily redrawing that boundary.
Reflection helps shape the mind. Science changes survival curves.
And if longevity escape velocity remains ahead of us, the responsible response is not resignation. It is disciplined defiance.
References
World Health Organization. Noncommunicable diseases fact sheet. World Health Organization; 2024.
United Nations Department of Economic and Social Affairs. World Population Prospects 2024.
Singapore Ministry of Health. Statistics on life expectancy and health outcomes. Accessed 2026.
Ashish Chordia is the Co-founder and CEO of Elyx, leading the vision and day-to-day operations of Singapore’s first concierge longevity service.